Journal of the American Society of Nephrology, Vol 6, 1186-1196, Copyright © 1995 by American Society of Nephrology

REGULAR ARTICLES

Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin

RH Pichler, N Franceschini, BA Young, C Hugo, TF Andoh, EA Burdmann, SJ Shankland, CE Alpers, WM Bennett and WG Couser
Division of Nephrology, University of Washington Medical Center, Seattle, USA.

Low-salt-diet, cyclosporine (CsA; 15 mg/kg per day)-treated rats develop striped interstitial fibrosis, arteriolar hyalinosis, and azotemia similar to the chronic nephropathy observed in humans. To examine the role of angiotensin II in this model, rats on a low-salt diet were given CsA, CsA and the angiotensin II receptor Type I antagonist Losartan (10 mg/kg per day), CsA and hydralazine/furosemide, or vehicle. At Day 35, CsA-treated rats had tubular injury, arteriolopathy of the afferent arteriole, increased expression of the monocyte-macrophage adhesive protein osteopontin, interstitial macrophage infiltration, increased interstitial transforming growth factor-beta expression, and interstitial fibrosis. This study provides new insight in both pathogenic and therapeutic aspects of CsA nephropathy. The pathogenesis of CsA nephropathy involves the expression of osteopontin by tubular epithelial cells, the level of which closely correlates with the degree of macrophage infiltration and interstitial fibrosis in all groups (r = 0.79 and 0.74, respectively; P < 0.001). Therapeutic conclusions can be drawn from the observation that both losartan and hydralazine/furosemide reduced osteopontin expression, macrophage infiltration, transforming growth factor-beta expression, and interstitial fibrosis, but did not prevent the decrease in GFR. Treatment with losartan, but not with hydralazine and furosemide, markedly reduced arteriolopathy. It was concluded that angiotensin II contributes to the vasculopathy (hyalinosis) induced by CsA. In contrast, the interstitial fibrosis mediated by CsA can be partially prevented by both an angiotensin II Type I receptor antagonist or by hydralazine and furosemide. This suggests that the interstitial fibrosis can be dissociated from the vascular effects of CsA. The beneficial effects of lowering blood pressure or vasodilation per se may be difficult to distinguish from the specific effects of angiotensin II receptor blockade.

This article has been cited by other articles:

				J. Y. Ghee, D. H. Han, H. K. Song, W. Y. Kim, S. H. Kim, H. E. Yoon, B. S. Choi, Y. S. Kim, J. Kim, and C. W. Yang The role of macrophage in the pathogenesis of chronic cyclosporine-induced nephropathy Nephrol. Dial. Transplant., December 1, 2008; 23(12): 4061 - 4069. [Abstract] [Full Text] [PDF]

				G. Capasso, C. I. Di Gennaro, F. D. Ragione, C. Manna, R. Ciarcia, S. Florio, A. Perna, R. M. Pollastro, S. Damiano, O. Mazzoni, et al. In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1186 - 1195. [Abstract] [Full Text] [PDF]

				N. A. Bobadilla and G. Gamba New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone Am J Physiol Renal Physiol, July 1, 2007; 293(1): F2 - F9. [Abstract] [Full Text] [PDF]

				D. Cibulskyte, M. Pedersen, A. Horlyck, N. Marcussen, H. E. Hansen, J. Frokiaer, M. Madsen, and J. Mortensen Telmisartan attenuates chronic ciclosporin A nephrotoxicity in a pig model Nephrol. Dial. Transplant., February 1, 2007; 22(2): 369 - 375. [Abstract] [Full Text] [PDF]

				C. Rosenberger, J. Pratschke, B. Rudolph, S. N. Heyman, R. Schindler, N. Babel, K.-U. Eckardt, U. Frei, S. Rosen, and P. Reinke Immunohistochemical Detection of Hypoxia-Inducible Factor-1{alpha} in Human Renal Allograft Biopsies J. Am. Soc. Nephrol., January 1, 2007; 18(1): 343 - 351. [Abstract] [Full Text] [PDF]

				R. J. Johnson, M. S. Segal, T. Srinivas, A. Ejaz, W. Mu, C. Roncal, L. G. Sanchez-Lozada, M. Gersch, B. Rodriguez-Iturbe, D.-H. Kang, et al. Essential Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenetic Link? J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1909 - 1919. [Abstract] [Full Text] [PDF]

				S.-i. Takeda, M. Takahashi, Y. Sado, K. Takeuchi, Y. Hakamata, H. Shimizu, T. Kaneko, H. Yamamoto, C. Ito, S. Ookawara, et al. Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2228 - 2236. [Abstract] [Full Text] [PDF]

				C. Li, C. W. Yang, J. H. Park, S. W. Lim, B. K. Sun, J. Y. Jung, S. B. Kim, Y. S. Kim, J. Kim, and B. K. Bang Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy Am J Physiol Renal Physiol, January 1, 2004; 286(1): F46 - F57. [Abstract] [Full Text] [PDF]

				A. W. Cowley Jr., T. Mori, D. Mattson, and A.-P. Zou Role of renal NO production in the regulation of medullary blood flow Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1355 - R1369. [Abstract] [Full Text] [PDF]

				M. Nava, Y. Quiroz, N. Vaziri, and B. Rodriguez-Iturbe Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats Am J Physiol Renal Physiol, March 1, 2003; 284(3): F447 - F454. [Abstract] [Full Text] [PDF]

				C. Li, C. W. Yang, W. Y. Kim, J. Y. Jung, J. H. Cha, Y. S. Kim, J. Kim, W. M. Bennett, and B. K. Bang Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine Am J Physiol Renal Physiol, February 1, 2003; 284(2): F389 - F398. [Abstract] [Full Text] [PDF]

				V. Alvarez, Y. Quiroz, M. Nava, H. Pons, and B. Rodriguez-Iturbe Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells Am J Physiol Renal Physiol, November 1, 2002; 283(5): F1132 - F1141. [Abstract] [Full Text] [PDF]

				D. J. Kelly, J. L. Wilkinson-Berka, S. D. Ricardo, A. J. Cox, and R. E. Gilbert Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats Nephrol. Dial. Transplant., June 1, 2002; 17(6): 985 - 991. [Abstract] [Full Text] [PDF]

				A. Verhulst, V. P. Persy, A. R. Van Rompay, W. A. Verstrepen, M. F. Helbert, and M. E. De Broe Osteopontin Synthesis and Localization along the Human Nephron J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1210 - 1218. [Abstract] [Full Text] [PDF]

				R. J. Johnson, J. Herrera-Acosta, G. F. Schreiner, and B. Rodriguez-Iturbe Subtle Acquired Renal Injury as a Mechanism of Salt-Sensitive Hypertension N. Engl. J. Med., March 21, 2002; 346(12): 913 - 923. [Full Text] [PDF]

				D.-H. Kang, J. Kanellis, C. Hugo, L. Truong, S. Anderson, D. Kerjaschki, G. F. Schreiner, and R. J. Johnson Role of the Microvascular Endothelium in Progressive Renal Disease J. Am. Soc. Nephrol., March 1, 2002; 13(3): 806 - 816. [Abstract] [Full Text] [PDF]

				M. Mazzali, T. Kipari, V. Ophascharoensuk, J.A. Wesson, R. Johnson, and J. Hughes Osteopontin--a molecule for all seasons QJM, January 1, 2002; 95(1): 3 - 13. [Full Text] [PDF]

				Y. Quiroz, H. Pons, K. L. Gordon, J. Rincon, M. Chavez, G. Parra, J. Herrera-Acosta, D. Gomez-Garre, R. Largo, J. Egido, et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition Am J Physiol Renal Physiol, July 1, 2001; 281(1): F38 - F47. [Abstract] [Full Text] [PDF]

				D.-H. KANG, J. HUGHES, M. MAZZALI, G. F. SCHREINER, and R. J. JOHNSON Impaired Angiogenesis in the Remnant Kidney Model: II. Vascular Endothelial Growth Factor Administration Reduces Renal Fibrosis and Stabilizes Renal Function J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1448 - 1457. [Abstract] [Full Text] [PDF]

				Y. Nagasawa, M. Takenaka, J. Kaimori, Y. Matsuoka, Y. Akagi, M. Tsujie, E. Imai, and M. Hori Rapid and diverse changes of gene expression in the kidneys of protein-overload proteinuria mice detected by microarray analysis Nephrol. Dial. Transplant., May 1, 2001; 16(5): 923 - 931. [Abstract] [Full Text] [PDF]

				D.-H. Kang, Y.-G. Kim, T. F. Andoh, K. L. Gordon, S.-I. Suga, M. Mazzali, J. A. Jefferson, J. Hughes, W. Bennett, G. F. Schreiner, et al. Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor Am J Physiol Renal Physiol, April 1, 2001; 280(4): F727 - F736. [Abstract] [Full Text] [PDF]

				K. IIJIMA, K. HAMAHIRA, A. KOBAYASHI, H. NAKAMURA, and N. YOSHIKAWA Immunohistochemical Analysis of Renin Activity in Chronic Cyclosporine Nephropathy in Childhood Nephrotic Syndrome J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2265 - 2271. [Abstract] [Full Text]

				J. M. BONVINI, U. SCHATZMANN, B. BECK-SCHIMMER, L. K. SUN, S. R. RITTLING, D. T. DENHARDT, M. LE HIR, and R. P. WÜTHRICH Lack of In Vivo Function of Osteopontin in Experimental Anti-GBM Nephritis J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1647 - 1655. [Abstract] [Full Text]

				S. D. Ricardo, D. F. Franzoni, C. D. Roesener, J. M. Crisman, and J. R. Diamond Angiotensinogen and AT1 antisense inhibition of osteopontin translation in rat proximal tubular cells Am J Physiol Renal Physiol, May 1, 2000; 278(5): F708 - F716. [Abstract] [Full Text] [PDF]

				M. NANGAKU, J. PIPPIN, and W. G. COUSER Complement Membrane Attack Complex (C5b-9) Mediates Interstitial Disease in Experimental Nephrotic Syndrome J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2323 - 2331. [Abstract] [Full Text]

				N. A. Bobadilla, E. Tapia, F. Jimenez, L. G. Sanchez-Lozada, J. Santamaria, A. Monjardin, A. Bolio, G. Gamba, and J. Herrera-Acosta Dexamethasone increases eNOS gene expression and prevents renal vasoconstriction induced by cyclosporin Am J Physiol Renal Physiol, September 1, 1999; 277(3): F464 - F471. [Abstract] [Full Text] [PDF]

				R. J. Johnson, K. L. Gordon, S. Suga, A. M. Duijvestijn, K. Griffin, and A. Bidani Renal Injury and Salt-Sensitive Hypertension After Exposure to Catecholamines Hypertension, July 1, 1999; 34(1): 151 - 159. [Abstract] [Full Text] [PDF]

				K. L. HUDKINS, C. M. GIACHELLI, YAN CUI, W. G. COUSER, R. J. JOHNSON, and C. E. ALPERS Osteopontin Expression in Fetal and Mature Human Kidney J. Am. Soc. Nephrol., March 1, 1999; 10(3): 444 - 457. [Abstract] [Full Text]

				X. Q. Yu, J.-M. Fan, D. J. Nikolic-Paterson, N. Yang, W. Mu, R. Pichler, R. J. Johnson, R. C. Atkins, and H. Y. Lan IL-1 Up-Regulates Osteopontin Expression in Experimental Crescentic Glomerulonephritis in the Rat Am. J. Pathol., March 1, 1999; 154(3): 833 - 841. [Abstract] [Full Text] [PDF]

				M. Mai, K. F. Hilgers, and H. Geiger Experimental Studies on the Role of Intercellular Adhesion Molecule-1 and Lymphocyte Function–Associated Antigen-1 in Hypertensive Nephrosclerosis Hypertension, December 1, 1996; 28(6): 973 - 979. [Abstract] [Full Text]

				B. Rodriguez-Iturbe, Y. Quiroz, M. Nava, L. Bonet, M. Chavez, J. Herrera-Acosta, R. J. Johnson, and H. A. Pons Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats Am J Physiol Renal Physiol, February 1, 2002; 282(2): F191 - F201. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673